0001415889-24-003395.txt : 20240212
0001415889-24-003395.hdr.sgml : 20240212
20240212171031
ACCESSION NUMBER: 0001415889-24-003395
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240208
FILED AS OF DATE: 20240212
DATE AS OF CHANGE: 20240212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Posner Christopher
CENTRAL INDEX KEY: 0001748265
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36279
FILM NUMBER: 24621170
MAIL ADDRESS:
STREET 1: C/O CARA THERAPEUTICS, INC.
STREET 2: 4 STAMFORD PLAZA, 107 ELM STREET, 9TH FL
CITY: STAMFORD
STATE: CT
ZIP: 06902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cara Therapeutics, Inc.
CENTRAL INDEX KEY: 0001346830
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 ATLANTIC STREET, SUITE 500
CITY: STAMFORD
STATE: CT
ZIP: 06901
BUSINESS PHONE: 203-406-3700
MAIL ADDRESS:
STREET 1: 400 ATLANTIC STREET, SUITE 500
CITY: STAMFORD
STATE: CT
ZIP: 06901
FORMER COMPANY:
FORMER CONFORMED NAME: Cara Therapeutics Inc
DATE OF NAME CHANGE: 20051213
4
1
form4-02122024_100215.xml
X0508
4
2024-02-08
0001346830
Cara Therapeutics, Inc.
CARA
0001748265
Posner Christopher
C/O CARA THERAPEUTICS, INC.
400 ATLANTIC STREET, SUITE 500
STAMFORD
CT
06901
true
true
false
false
PRESIDENT AND CEO
0
Common Stock
2024-02-08
4
S
0
35575
0.53
D
186355
D
This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person on November 2, 2022 in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person.
/s/ Darren DeStefano, Attorney-in-Fact
2024-02-12